5 Specialty Chemical Stocks FIIs Are Betting On in 2025
In 2025, the spotlight has shifted to India’s specialty chemical sector — a space quietly accumulating foreign capital and silently delivering multibagger returns.
While retail investors are busy chasing trending themes, FIIs (Foreign Institutional Investors) are accumulating select chemical stocks with robust fundamentals, export demand, and moat-worthy businesses.
Here are 5 specialty chemical stocks that smart foreign investors are quietly adding to their portfolios — and why you might want to track them too.
1. Aarti Industries
Once seen as a commodity player, Aarti has transformed into a global specialty chemical exporter with long-term contracts from pharma and agrochemical giants. FIIs increased their stake from ~9.5% to 11.2% over the last two quarters — a strong signal of long-term confidence.
2. Clean Science & Technology
This green chemical manufacturer is a rare debt-free company with >50% export revenue. It’s a favorite among ESG-aligned funds, and foreign institutions now hold over 14% in this silent wealth creator.
3. Navin Fluorine International
With aggressive expansion in fluorochemicals and a rs.4989+ price tag, this stock still finds takers among global funds. Its new Dahej plant and USFDA-compliant facilities have attracted serious long-term FII interest.
4. Alkyl Amines Chemicals
Known for its monopoly in aliphatic amines, Alkyl is a classic high-margin, high-growth stock. FIIs trimmed slightly in 2023, but resumed buying in 2025 after capacity expansion announcements and consistent quarterly results.
5. SRF Ltd
Though SRF is a diversified player, its chemical business alone is larger than many standalone companies. From refrigerants to packaging films, it’s a multi-business beast that foreign funds love for its balance of growth + stability.
Why FIIs Love Specialty Chemicals
-
China+1 supply shift is now in execution phase, not theory
-
High export revenue = Dollar advantage
-
Strong pricing power + high margins
-
Govt PLI schemes and infra support
-
Niche segments → Less competition, better moat
⚠️ A Personal Missed Opportunity
Back in 2021, I had a chance to buy Clean Science at IPO around ₹900. I skipped it thinking “it’s overhyped.” Today in 2025, it’s up nearly 2.5x — and still FII-heavy.
The lesson? Sometimes, boring businesses compound the fastest.
Final Thoughts
While everyone is looking at largecaps and PSU stories, specialty chemicals offer a hidden runway for massive wealth creation. Watch what the foreign smart money is doing — and act before the retail crowd catches up.
You don’t need to guess the next multibagger — just follow the FII footprints.
Frequently Asked Questions


Please do not enter any spam link in the comment box.